Keith Valentine - Jan 5, 2023 Form 3 Insider Report for Orthofix Medical Inc. (OFIX)

Signature
/s/ Patrick Keran, attorney-in-fact
Stock symbol
OFIX
Transactions as of
Jan 5, 2023
Transactions value $
$0
Form type
3
Date filed
1/9/2023, 05:13 PM
Previous filing
Jan 3, 2023
Next filing
Feb 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OFIX Common Stock 259K Jan 5, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OFIX Employee Stock Option (Right to Buy) Jan 5, 2023 Common Stock 135K $37.67 Direct F3, F4
holding OFIX Employee Stock Option (Right to Buy) Jan 5, 2023 Common Stock 62.1K $34.09 Direct F5, F6
holding OFIX Employee Stock Option (Right to Buy) Jan 5, 2023 Common Stock 32.4K $43.82 Direct F7, F8
holding OFIX Employee Stock Option (Right to Buy) Jan 5, 2023 Common Stock 50.7K $28.85 Direct F9, F10
holding OFIX Employee Stock Option (Right to Buy) Jan 5, 2023 Common Stock 3.69K $23.86 Direct F11, F12
holding OFIX Employee Stock Option (Right to Buy) Jan 5, 2023 Common Stock 109K $40.50 Direct F13, F14
holding OFIX Employee Stock Option (Right to Buy) Jan 5, 2023 Common Stock 13.3K $36.04 Direct F15, F16
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 120,381 of unvested restricted stock units, of which 21,810 unvested restricted stock units vest in equal installments on each of January 28, 2023 and 2024 and 98,571 unvested restricted stock units vest in equal installments on each of February 28, 2023, 2024 and 2025.
F2 Acquired pursuant to the terms of the merger between the Issuer and SeaSpine Holdings Corporation ("SeaSpine") which became effective on January 5, 2023 (the "Merger"), in exchange for 622,968 shares and unvested restricted stock units of SeaSpine, shares having a market value of $22.76 per share at the effective time of the Merger.
F3 The option vested as to 25% of the underlying shares on May 1, 2016 and the remaining 75% vested in twelve substantially equal quarterly installments thereafter.
F4 The option was assumed by Issuer in connection with the Merger and replaced 325,000 SeaSpine options at an exercise price of $15.68.
F5 The option vested as to 6.25% on June 1, 2016, 6.25% on June 30, 2016 and the remaining 87.5% vested in fourteen equal quarterly installments thereafter.
F6 The option was assumed by Issuer in connection with the Merger and replaced 149,074 SeaSpine options with an exercise price of $14.19.
F7 The option vested as to 25% of the underlying shares on January 1, 2020 and the remaining 75% vested or vests, as applicable, in twelve substantially equal quarterly installments thereafter.
F8 The option was assumed by Issuer in connection with the Merger and replaced 77,881 SeaSpine options with an exercise price of $18.24.
F9 The option vested as to 25% of the underlying shares on January 1, 2021 and the remaining 75% vested or vests, as applicable, in twelve substantially equal quarterly installments thereafter.
F10 The option was assumed by Issuer in connection with the Merger and replaced 121,830 SeaSpine options with an exercise price of $12.01.
F11 The option fully vested and became exercisable on June 21, 2020.
F12 The option was assumed by Issuer in connection with the Merger and replaced 8,871 SeaSpine with an exercise price of $9.93.
F13 The option vests as to 25% of the underlying shares on January 28, 2022 and the remaining 75% vests in twelve substantially equal quarterly installments thereafter.
F14 The option was assumed by Issuer in connection with the Merger and replaced 261,699 SeaSpine optons with an exercise price of $16.86.
F15 The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% vests in twelve substantially equal quarterly installments thereafter.
F16 The option was assumed by Issuer in connection with the Merger and replaced 31,866 SeaSpine options with an exercise price of $15.00.